Pfizer COVID 19 Pill Shows Effectiveness Against Omicron Variant

• A COVID 19 pill manufactured by vaccine provider Pfizer has been reported to be highly effective at protecting against severe symptoms of coronavirus

• The Paxlovid pill is also effective against the fast-spreading Omicron variant, according to lab testing

• During clinical trials, Paxlovid was 90% effective at preventing hospitalization and death in high-risk COVID 19 patients

A pill developed by vaccine manufacturing company Pfizer has been proven to be effective against severe symptoms of COVID 19, the company as revealed.

The experimental pill named Paxlovid was also reported to be effective against the rapidly spreading Omciron variant, according to laboratory testing done by Pfizer.

During the clinical trials, Paxlovid showed almost 90% efficacy against COVID 19 by preventing hospitalization and death in high-risk patients.

This success has warranted Pfizer to seek authorization from the US Food and Drug Administration (FDA) for the pill to be made available for combating coronavirus.

This comes a month after the United Kingdom approved the use of another COVID 19 pill, Molnupiravir that was manufactured by Merck/Ridgeback.

Read also: Needle-free COVID 19 Vaccine Tested in the UK

The use of Molnupiravir was however stalled in the US due to safety concerns.

Pfizer hopes that the results of the laboratory testing will be enough to convince the FDA to approve the new pill.

Follow Naija.fm on our social media handles Facebook, Instagram, and Twitter to keep up with trending news, breaking news, entertainment news, and hot gist.